<div class="card">
  <img src="https://bloximages.chicago2.vip.townnews.com/tdn.com/content/tncms/assets/v3/editorial/6/a3/6a355258-b89d-5567-9002-15b24bcaeb66/68625b50355bc.image.jpg?crop=1286%2C675%2C0%2C60&order=crop%2Cresize&resize=1200%2C630" alt="Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms" style="width:100%; height:180px; object-fit:cover; border-radius:5px;">
  <div style="padding:10px">
    <h3>Innovent Biologics Showcases "Dual Innovations" at Oncology R&D Day, Pioneering the Future of Cancer Treatment with Next-Generation IO and ADC Platforms</h3>
    <p>SAN FRANCISCO and SUZHOU, China, June 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major...</p>
    <a href="https://tdn.com/online_features/press_releases/article_7082d109-0c57-5d1d-a544-ff6a3d36adb9.html" target="_blank" style="color:red">Read More â†’</a>
  </div>
</div>

